PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.46%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
-41.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
14800.00%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
14800.00%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
445.83%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
444.12%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
444.12%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-106.36%
Negative OCF growth while VALMT.HE is at 13.11%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-150.08%
Negative FCF growth while VALMT.HE is at 60.29%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-0.63%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 90.07%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-1.75%
Negative 5Y CAGR while VALMT.HE stands at 43.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-1.70%
Negative 3Y CAGR while VALMT.HE stands at 14.65%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
57.19%
10Y OCF/share CAGR under 50% of VALMT.HE's 161.21%. Michael Burry would worry about a persistent underperformance in cash creation.
-121.47%
Negative 5Y OCF/share CAGR while VALMT.HE is at 273.63%. Joel Greenblatt would question the firm’s operational model or cost structure.
-147.18%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-45.61%
Negative 10Y net income/share CAGR while VALMT.HE is at 859.65%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-78.25%
Negative 5Y net income/share CAGR while VALMT.HE is 46.73%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-79.10%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
109.02%
10Y equity/share CAGR at 50-75% of VALMT.HE's 152.44%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
36.19%
Below 50% of VALMT.HE's 122.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
20.75%
Below 50% of VALMT.HE's 80.19%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.70%
Our AR growth while VALMT.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
11.16%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.21%
Negative asset growth while VALMT.HE invests at 1.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.35%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.78%
Debt shrinking faster vs. VALMT.HE's 14.69%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-100.00%
Our R&D shrinks while VALMT.HE invests at 3.13%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.